PPAR-γ is selectively upregulated in Caco-2 cells by butyrate.

被引：87

作者：

Wächtershäuser, A ^{[1
]}

Loitsch, SM ^{[1
]}

Stein, J ^{[1
]}

机构：

[1] Goethe Univ Frankfurt, Dept Med 2, D-60590 Frankfurt, Germany

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2000年 / 272卷 / 02期

关键词：

butyrate; Caco-2; cells; differentiation; PPAR;

D O I：

10.1006/bbrc.2000.2793

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The peroxisome proliferator-activated receptor (PPAR)-gamma is a nuclear lipid-activable receptor controlling the expression of genes involved in lipid metabolism and adipocyte differentiation. In order to investigate the possible role of PPAR-gamma in the differentiation of intestinal epithelial cells, we examined its expression in the human colon carcinoma cell line Caco-2, which undergoes rapid cell differentiation in the presence of butyrate. PPARs were quantified on mRNA level by RT competitive multiplex PCR, the corresponding proteins were determined by Western blot. In contrast to PPAR-alpha and PPAR-beta, PPAR-gamma mRNA and protein increased significantly in butyrate-treated Caco-2 cells in a dose- and time-dependent manner. This effect was butyrate-specific, since no change in PPAR-gamma expression could be observed after incubation with propionate or valerate, Activation of PPAR-gamma by ciglitazone further increased butyrate-induced cell differentiation dose-dependently. These data demonstrate a role for PPAR-gamma in the regulation of cell differentiation in Caco-2 cells. (C) 2000 Academic Press.

引用

页码：380 / 385

页数：6

共 31 条

[1] Butyrate inhibits colon carcinoma cell growth through two distinct pathways [J].

Archer, S ;

Meng, SF ;

Wu, J ;

Johnson, J ;

Tang, R ;

Hodin, R .

SURGERY, 1998, 124 (02) :248-253

[2] Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].

Auboeuf, D ;

Rieusset, J ;

Fajas, L ;

Vallier, P ;

Frering, V ;

Riou, JP ;

Staels, P ;

Auwerx, J ;

Laville, M ;

Vidal, H .

DIABETES, 1997, 46 (08) :1319-1327

[3] Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells [J].

Brockman, JA ;

Gupta, RA ;

DuBois, RN .

GASTROENTEROLOGY, 1998, 115 (05) :1049-1055

[4] A RAPID AND VERSATILE METHOD TO SYNTHESIZE INTERNAL STANDARDS FOR COMPETITIVE PCR [J].

CELI, FS ;

ZENILMAN, ME ;

SHULDINER, AR .

NUCLEIC ACIDS RESEARCH, 1993, 21 (04) :1047-1047

[5]

Clarke SD, 1999, AM J CLIN NUTR, V70, P566

[6] Peroxisome proliferator-activated receptors: Nuclear control of metabolism [J].

Desvergne, B ;

Wahli, W .

ENDOCRINE REVIEWS, 1999, 20 (05) :649-688

[7] The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers [J].

DuBois, RN ;

Gupta, R ;

Brockman, J ;

Reddy, BS ;

Krakow, SL ;

Lazar, MA .

CARCINOGENESIS, 1998, 19 (01) :49-53

[8] PPARγ3 mRNA:: a distinct PPARγ mRNA subtype transcribed from an independent promoter [J].

Fajas, L ;

Fruchart, JC ;

Auwerx, J .

FEBS LETTERS, 1998, 438 (1-2) :55-60

[9] 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA [J].

FORMAN, BM ;

TONTONOZ, P ;

CHEN, J ;

BRUN, RP ;

SPIEGELMAN, BM ;

EVANS, RM .

CELL, 1995, 83 (05) :803-812

[10]

GASCHOTT T, 2000, IN PRESS INT J CANC

← 1 2 3 4 →